Microbial surface carbohydrate patterns

Microbial surface carbohydrate patterns, also known as microbial glycans or cell surface polysaccharides, are complex sugar structures found on the exterior of bacteria, fungi, viruses, and parasites. These patterns include capsular polysaccharides, lipopolysaccharides (LPS), and teichoic acids, which serve critical roles in maintaining structural integrity, facilitating adhesion to host tissues, and enabling immune evasion [1.1.1, 1.2.4]. In the context of drug development, these carbohydrates are primary targets for glycoconjugate vaccines, which link the polysaccharides to carrier proteins to elicit a robust T-cell dependent immune response [1.2.1, 1.2.2]. Additionally, certain antibiotics like polymyxins target these patterns (specifically LPS) to disrupt the microbial membrane, while others inhibit the biosynthetic pathways that produce these essential surface components [1.1.1, 1.1.3]. Because many of these carbohydrate motifs are unique to microbes and absent in humans, they provide a high degree of selectivity for therapeutic intervention [1.1.5]. However, challenges such as molecular mimicry, where microbial glycans resemble host structures, and the high diversity of serotypes must be managed to avoid autoimmunity or reduced efficacy [1.2.1, 1.2.4]. These targets are also utilized in diagnostics, where specific carbohydrate biomarkers like galactomannan are used to detect invasive fungal infections [1.1.4]. Overall, microbial surface carbohydrates represent a diverse and essential class of targets for both preventative and therapeutic antimicrobial strategies.

Other names

Microbial glycansCell surface carbohydratesCell wall polysaccharidesCapsular polysaccharidesPathogen-associated molecular patterns (carbohydrate-based)Bacterial surface glycans

Induction of opsonophagocytic antibodies (vaccines), disruption of cell membrane integrity (polymyxins), and inhibition of cell wall biosynthesis.